首页> 美国卫生研究院文献>BMJ Case Reports >Unusual presentation of more common disease/injury: Efficacy of administration of coagulation factor XIII with definitive surgery for multiple intractable enterocutaneous fistulae in a patient with decreased factor XIII activity
【2h】

Unusual presentation of more common disease/injury: Efficacy of administration of coagulation factor XIII with definitive surgery for multiple intractable enterocutaneous fistulae in a patient with decreased factor XIII activity

机译:不常见的更常见疾病/伤害的表现:凝血因子XIII的明确手术对XIII活性降低的患者的多发性难治性肠皮瘘的治疗效果

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Enterocutaneous fistulae (ECF) are challenging problem commonly encountered by surgeons and cause significant complications. They not only prolong hospital stay, but also restrict a patient’s activities of daily living. The authors report a case of successful treatment of multiple intractable ECF in a patient with decreased coagulation factor XIII (FXIII) activity using intravenous FXIII treatment. A 74-year-old man with multiple ECF was referred. Although no factors involved in impaired wound were initially identified, he developed ECF after multiple surgical interventions with repeated wound dehiscence. FXIII activity was below the normal value. A definitive operation was performed and FXIII was administrated for 5 days postoperatively. There was no fistula recurrence and no other complications. Preoperative assessment of factors related to wound repair, such as FXIII activity, may be important for patients with wound dehiscence and subsequent fistula development and should be considered in patients who are resistant to standard treatments.
机译:肠皮肤瘘(ECF)是外科医生通常遇到的具有挑战性的问题,并引起严重的并发症。它们不仅延长了住院时间,而且限制了患者的日常生活。作者报告了通过静脉内FXIII治疗成功治疗多发性顽固性ECF的患者,该患者的凝血因子XIII(FXIII)活性降低。推荐了一名具有多个ECF的74岁男子。尽管最初没有发现与伤口受损有关的因素,但他在多次外科手术中反复伤口裂开后发展了ECF。 FXIII活性低于正常值。进行了确定的手术,并且在术后5天给予FXIII。没有瘘管复发,也没有其他并发症。术前评估与伤口修复相关的因素,例如FXIII活性,对于伤口裂开和随后的瘘管发展的患者可能很重要,对标准治疗有抗药性的患者应考虑进行评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号